FOB Savings Reduced To $6.4 Bil. In Revised Budget Outlook; Total Drug Savings, $100 Bil.
This article was originally published in The Pink Sheet Daily
Executive Summary
The administration's expectations for savings from follow-on biologics that can be applied to health care reform are clarified by the mid-year budget review and outlook released by OMB Aug. 25.